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Curiosity first, applications later 
Tebello Nyokong speaks to Robert Berold and Janice Limson about her 
career as a chemist 
TEBELLO NYOKONG, WHO HOLDS A research chair in medicinal chemistry and nanotechnology at Rhodes Uni-
versity, has become the first South African 
scientist to win the COreal-UNESCO 
award for women in science, in the physical 
sciences. Only one laureate is selected 
from each of five world regions, and 
Nyokong is the 2009 laureate for Africa 
and the Arab states. She and the winners 
from the other four regions travel to Paris 
in March to each accept the award and a 
generous prize of close to R1 million. 
Nyokong researches the group of 
highly coloured compounds called 
phthalocyanines which are related to 
porphyrins-the dye used in blue jeans is 
porphyrin-based, as is haemoglobin, 
which gives the red colour to blood. These 
compounds have widespread application 
as catalysts of chemical and biological 
reactions, and have been used as potent 
therapies for cancer, as highly sensitive 
sensors for detecting pathogens, and in 
the cleaning of polluted water. 'I fell in 
love with phthalocyanines: she says. 
'They are well behaved, stable, and very 
colourful-they are beautiful molecules. 
For my Ph.D. I was trying to investigate 
whether we could make them water 
soluble.' 
At that stage there was no thought of 
applications: 'But you know, most research 
that goes anywhere is not based on appli-
cations. Curiosity-driven research is how 
most discoveries are made. The applica-
tions come later.' 
By altering the chemical structure of 
phthalocyanines-by changing their 
metal centres, adding substituents, or 
coupling them with enzymes or nano-
particles such as quantum dots-it 
becomes possible to finely tune and 
manipulate their properties. The research 
by Nyokong and her team into early 
warning systems for diseases and environ-
mental toxins has resulted in the develop-
ment of several sensors, including the 
most sensitive detection system yet devel-
oped for the neurotransmitter nitric oxide. 
targeting of the specific biological markers 
of certain cancers, allows for early diagno-
sis. The third tier is cancer treatment, and 
porphyrin-based cancer drugs developed 
by Nyokong and her team over several 
years are currently undergOing pre-clinical 
trials in South Africa. 
More recently, with the opportunities 
afforded by nanostructured materials, 
this research has entered a new phase, 
combining the phenomenal physical and 
chemical properties of nanostructures 
with the catalytic properties of synthetic 
porphyrin molecules. This work is an 
extension of photodynamic therapy-the 
use of specially developed dyes to direct 
deadly light onto cancer cells-which is 
being researched worldwide as an alter-
native to chemotherapy. In photodynamic 
therapy, the dye is injected into the blood-
stream or, for skin cancer, applied directly 
to the skin. 
When photodynamic therapy is com-
bined with quantum dots, cancer cells can 
be killed even more efficiently. Quantum 
dots are particles in the nano range which 
can be connected to biological molecules, 
and so can be directed to targeted biolOgi-
cal systems for imaging. They can absorb 
and re-emit light, so once they are in the 
target area, their fluorescence can then be 
used to detect tumours. 
Nyokong has been one of the very first 
proponents of the phthalocyanine-nano-
structure hybrid approach, and one of the 
first to extend the field beyond photody-
namic therapy to sensing systems. Her 
breakthrough came when she was able to 
chemically couple phthalocyanines either 
with nanostructures such as multi-walled 
and single-walled carbon nanotubes, or 
directly to enzymes. 'Someone from the 
National Laser Centre called me at 10 pm 
one night-they wanted to come the next 
day to discuss the possibility of loaning 
me some lasers. I knew this was a great 
opportunity, because I needed lasers to 
study the molecules we make in the lab.' 
Laser technology has since Significantly 
improved her research in photodynamic 
therapy. 
Nyokong intends to invest some of her 
One application is in combating cancer, 
and here Nyokong's research takes a 
three-tiered approach. The first tier, sensor 
research, aims to detect and target cancer-
causing agents before they can do any 
harm to the human body. The next tier, Tebello Nyokong (centre) leading by example. 
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prize into seeing these compounds success-
fully through the developmental, trial 
and safety testing stages so that they 
could become available on the market in 
the years to come: 'All the trials take 
forever- there are so many restrictions 
and conditions. Someone else can do that. 
But we've found one drug that is really 
going to be a big one. We've tested it on 
cells and it's brilliant. We are still doing 
more trials before we patent it, but we re-
ally think it's going to be a world-class 
South African drug.' 
Another branch of Nyokong's research 
is photo sensitised oxidation for pollution 
control. Photochemical destruction of 
certain pollutants, such as chlorinated 
phenols and other pesticides, is commonly 
done with ultraviolet light. However, the 
products of photodegradation after such 
ultraviolet treatment can be more toxic 
than the parent compounds. A possible 
alternative is photo sensitised oxidation. 
Nyokong is investigating the use of 
phthalocyanines as photosensitisers to 
transform chlorinated phenols and other 
pollutants into less harmful products. 
Nyokong's own story speaks eloquently 
of her tremendous commitment and pas-
sion for science. She was raised in Sharpe-
ville, but her family left for Lesotho soon 
after the infamous 1960 massacre. Her 
Pan-Africanist father believed strongly in 
educfltion for girls, but at the same time 
his three daughters were expected to 
contribute by helping out in the family's 
construction business, planting, weeding 
and harvesting the extensive vegetable 
garden, and cleaning the house. 
Tebello olfly started school when she 
was eight years old. 'I was staying with 
my paternal grandmother in the Free 
State. In those days you were not permit-
ted to enter primary school until you 
could reach over your head and touch 
your opposite ear, using your hand. I 
could only do this when I was eight years 
old. Having a short arm was not good for 
one's intellectual development!' She went 
on to school in Lesotho, and remembers 
fondly the devotion and discipline of her 
(mostly female) teachers. It was a poor 
school, with parents and churches having 
to build classrooms, and some classes held 
under a tree. She saw that with dedicated 
teachers 'one can learn even in very 
difficult situations. Yes it would be nice to 
have good classrooms, but if they are not 
there, learning can go on! We were even 
very proud of our classroom under the 
tree.' 
She excelled at science, but a career in 
chemistry was not her first choice. 'To be 
honest I did not even know what jobs one 
could get as a chemistry graduate. Like 
many young people, I wanted to be a 
doctor.' This ambition had to be shelved 
because her father became too ill for her 
to take up offers of a dentistry or medical 
scholarship abroad. So she decided to 
study chemistry in Lesotho and become 
a high school teacher. Then she won a 
postgraduate scholarship in Canada. 'By 
that time I loved chemistry fully, and I 
began to see that even though doctors 
cure patients, it ~s chemists that develop 
the medicines. Being a doctor was no 
longer so important to me.' 
While still at university, Nyokong 
married and had two children. She 
admits that being a young mother while 
studying for her Ph.D. and working as a 
cash-strapped teaching assistant was 
'very difficult'. Nor did these difficulties 
end when her doctorate was completed. 
Research was a lonely road. 'I had no one 
to talk to among my.peers when things 
went wrong with my research or even 
when I got very excited about my research. 
I experienced-and still experience-
academic loneliness.' 
Racism and sexism were additional 
hurdles when she arrived at Rhodes as a 
lecturer in 1992. 'Clearly Rhodes chemistry 
students had never been taught by a black 
person, let alone a black woman. There 
were some difficulties at the beginning 
which I soon overcame. But one had to be 
very firm!' By 2001 she was a full professor, 
and she has now trained close to 30 M.Sc. 
and Ph.D. students. 'Many of these 
children (I can call them children because 
I'm older now) come from rural back-
grounds. I think they gravitate towards 
me because they also know I've come 
from there.' Some have gone on to become 
lecturers in chemistry, some have emi-
grated, and some are in industry. 'I get 
tired, though, when I see how many 
graduates are money-driven. You should 
just work for what you are paid for. It' s all 
about commitment.' 
Nyokong now heads the new Nano-
technology Innovation Centre for medical 
sensors: the biggest single research invest-
ment in the history of Rhodes. Linked to 
other nanotechnology centres in the 
country, it is designed to bridge the 
gap between research and the market. 
Developing skills and human resource 
capacity in nanotechnology in South 
Africa is the centre's top priority, and 
it will conduct both fundamental and 
applied research towards the develop-
ment of sensors for early detection of 
disease. The centre will investigate new 
approaches in molecular immobilisation, 
using metal- and carbon-based nano-
particles and nanotubes. It will develop 
sensors for the rapid detection of medi-
cally important molecules (such as amino 
acids, thiols, neurotransmitters), and 
sensors for monitoring biological toxins. 
Peter Clayton, deputy vice-chancellor 
for research at Rhodes says, 'What Tebello 
Nyokong has achieved is quite staggering. 
She literally oozes passion for science-
doing it, teaching it, promoting it, financ-
ing it, and applying it.' 
Robert Berold is a writer based in Grahams-
town. 
Janice Limson is a senior lecturer in biotech-
nology at Rhodes University. 
